1.
J Med Life
; 12(3): 233-235, 2019.
Article
in English
| MEDLINE
| ID: mdl-31666823
ABSTRACT
Finding neuroprotective agents to counteract the deleterious effects of hypoxia on neuronal cells successfully is one of the most critical targets of clinical research since preclinical studies have identified potential neuroprotective strategies. In clinical practice, amantadine and piracetam are used with reasonable success. We present the cases of three patients with acute brain hypoxia secondary to cardiac arrest, to whom Cerebrolysin was added to the standard neuroprotective treatment regimen, leading to a notable improvement in functional outcome.
Subject(s)
Heart Arrest/complications , Heart Arrest/drug therapy , Hypoxia, Brain/drug therapy , Hypoxia, Brain/etiology , Nerve Growth Factors/therapeutic use , Acute Disease , Adult , Aged , Animals , Female , Humans , Male , Middle Aged , Neuroprotective Agents/therapeutic use
2.
Wiad Lek
; 40(6): 380-2, 1987 Mar 15.
Article
in Polish
| MEDLINE
| ID: mdl-3630151
3.
Ginekol Pol
; 57(2): 148-50, 1986 Feb.
Article
in Polish
| MEDLINE
| ID: mdl-3721281